
No results matched your search
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, the week did witness earnings releases from...
Nabriva Therapeutics (NBRV)trades 17.2% down premarketafterentering into a definitive agreement with healthcare-focused and institutional investors for the purchase and sale of...
Contemporary data demonstrate macrolide resistance in S. pneumoniae is 39.5 percent overall and greater than 25 percent in most regions of the country Macrolide resistance shown...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Sell | Strong Sell | Sell |
Technical Indicators | Strong Buy | Strong Buy | BUY | Strong Sell | Sell |
Summary | Strong Buy | Strong Buy | Neutral | Strong Sell | Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Bullish Engulfing | 5H | Current | |||
Harami Cross | 1D | Current | |||
Completed Patterns | |||||
Advance Block Bearish | 1H | 1 | Mar 05, 2021 20:00 | ||
Falling Three Methods | 1W | 2 | Feb 21, 2021 | ||
Doji Star Bearish | 30 | 2 | Mar 05, 2021 20:30 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Zenith Bank | 25.20 | 25.20 | 25.20 | -0.10 | -0.40% | 796.51K | 10:10:00 | ||
Guaranty Trust Bank | 31.50 | 31.50 | 31.50 | +0.50 | +1.61% | 0.93K | 10:00:00 | ||
UBA | 8.00 | 8.00 | 8.00 | +0.05 | +0.63% | 0.70K | 10:00:00 | ||
FBN Holdings | 7.10 | 7.10 | 7.10 | 0.00 | 0.00% | 53.77K | 10:00:00 | ||
MTN Nigeria | 167.90 | 167.90 | 167.90 | -2.10 | -1.24% | 7.01K | 10:06:00 | ||
United Capital | 4.650 | 4.620 | 4.610 | -0.410 | -8.17% | 1.04M | 10:10:00 | ||
Access Bank | 7.80 | 7.80 | 7.80 | 0.00 | 0.00% | 35.92K | 10:07:00 | ||
Jaiz Bank | 0.68 | 0.68 | 0.68 | +0.01 | +1.49% | 0.12K | 10:00:00 | ||
Conoil | 18.90 | 18.90 | 18.90 | 0.00 | 0.00% | 1.20K | 10:00:00 | ||
Fidson | 4.650 | 4.650 | 4.650 | 0.000 | 0.00% | 4.50K | 10:00:00 |
Nabriva Therapeutics plc is a biopharmaceutical company engaged in the commercialization and development of anti-infective agents to treat serious infections. The Company’s product XENLETA (lefamulin), is a semi-synthetic pleuromutilin antibiotic for systematic administration in humans. It inhibits the synthesis of bacterial protein, which is required for bacteria to grow by binding with high affinity, high specificity and at molecular targets that are different than other antibiotic classes. The Company is also developing CONTEPO (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review